Daksh Pharma Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Glimidac-MV1Forte Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glimidac-MV1Forte Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimidac-MV1Forte Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimidac-MV1Forte Tablet SR.
Glimidac-MV1Forte Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimidac-MV1Forte Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimidac-MV1Forte Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Glimidac-MV1Forte Tablet SR is a combination medication containing Glimepiride, Metformin, and Voglibose. This medicine is prescribed for type 2 diabetes mellitus (DM) to improve blood glucose levels in adults when combined with a healthy diet and exercise. Glimepiride increases insulin release from the pancreas, while Metformin reduces glucose production by the liver and improves insulin sensitivity. Voglibose acts as an alpha-glucosidase inhibitor, lowering postprandial (after meal) glucose levels.
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. It is important to monitor for signs of hypoglycemia.
Patients with known allergies to the medication's components or excipients should avoid its use. The medicine is also not recommended for patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis.
No, mixing alcohol with Glimidac-MV1Forte Tablet SR is not recommended. Alcohol can lower blood sugar levels and increase the risk of lactic acidosis.
Yes, using Glimidac-MV1Forte Tablet SR may lead to hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, a fast heart rate, and feeling anxious or shaky. It is more likely if you miss meals, drink alcohol, exercise excessively, or take other antidiabetic medications concurrently.
Store this medication in its original packaging, tightly sealed. Follow the recommended instructions on the packaging or label. Do not consume unused medication. Ensure that it is not accessible to pets, children, or others.